Show ratings & reviews for

3.5 Overall Rating

Effectiveness

Ease of Use

Satisfaction

Most voted positive review

1 People found this comment helpful

No noticeable side effects after over 1.5 years of taking Nubeqa (2 tablets twice a day). PSA was doubling every 3 months after 3 years of Eligard injections every 3 months. Going very quickly from 0.09 to 2.675 in 8 months. After consultation with my oncologist decided to add Nubeqa to the Eligard injections. PSA was reduced to 0.240 in 2 months. PSA has been steady at 0.048 so far in 2021. ...

Shared reviews and ratings

JZ | 65-74 | Male | On medication for 1 to 6 months | Patient
3/19/2023
Condition: metastatic castration-sensitive prostate cancer
Overall rating 2.0
Effectiveness
Ease of Use
Satisfaction

Five months taking Nubeqa and PSA has gone up a lot each month! Nubeqa is NOT having any effect on cancer!

Report this postFill 3Created with Sketch.
Greg J | 65-74 | Male | On medication for 1 to less than 2 years | Patient
8/3/2021
Condition: non-metastatic castration-resistant prostate cancer
Overall rating 5.0
Effectiveness
Ease of Use
Satisfaction

No noticeable side effects after over 1.5 years of taking Nubeqa (2 tablets twice a day). PSA was doubling every 3 months after 3 years of Eligard injections every 3 months. Going very quickly from 0.09 to 2.675 in 8 months. After consultation with my oncologist decided to add Nubeqa to the Eligard injections. PSA was reduced to 0.240 in 2 months. PSA has been steady at 0.048 so far in 2021. Very expensive but assistance is available.

Report this postFill 3Created with Sketch.

IMPORTANT INFORMATION ABOUT USER-GENERATED CONTENT ON WEBMD

The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions.

Read More